[1] Iravani M,Evazi M R,Mousavi S A,et al.2007.Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in highand standard-risk leukemic patients[J].Bone Marrow Transplantation,40:105-110.
[2] Bishop J B,Wasson J S.1986.Toxicological review of busulfan (Myleran)[J].Mutaiont Resrarch,168:15-45.
[3] Karl G,Rodeck U,Dicker A P.2007.Zebrafish:an emerging model system for human disease and drug discovery[J].Clinical Pharmacology and Therapeutic,.82:70-80.
[4] Goldsmith P.2004.Zebrafish as a pharmacological tool:the how,why and when.Curt.Opin[J].Pharmacology,4:504-512.
[5] Carney A S,Prasch L A,Heideman W,et al.2006.Understanding dioxin developmental toxicity using the zebrafish model.Birth[j].Birth Defects Research Part A:Clinical and Molecular Teratology,76:7-18.
[6] Cinma B,Weidinger G,Knaut H,et al.2002.Production of maternal-zygotic mutant zebrafish by germ-line replacement[J].Proceedings of the National Academy of Sciences of the United States of America,99:14919-14924.
[7] Doitsidou M,Reichman-Fried M,Stebler J,et al.2002.Guidance of primordial germ cell migration by the chemokine SDF-1[J].Cell,111:647-659.
[8] Fang R.1983.Gas exchange in fish swim bladder.Rev.Physiol.Biochem[J].Pharmacoogyl,97:111-158.
[9] Furukawa S,Usuda K,Abe M,et al.2007.Microencephaly and microphthalmia in rat fetuses by busulfan[J].Histology and histopathology,22:389-397.
[10] Hallare A,Nagel K,Kohler H,et al.2006.Comparative embryotoxicity and proteotoxieity of three carrier solvents to zebrafish (Danio rerio) embryos[J].Ecotoxicology and Environmental Safety,63:378-388.
[11] Kasuga F,Takahashi M.1986.The endocrine function of rat gonads with reduced number of germ cells following busulphan treatment[J].Endocrinoogy Japanese,33:105-115.
[12] Naruse T,Takahara M,Takagi M,et al.2007.Busulfan-induced central polydactyly,syndactyly and cleft hand or foot:a common mechanism of disruption leads to divergent phenotypes[J].Development,Growth and Differentiation,49:533-541.